Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 20/11/2019
SIETES contiene 92834 citas

 
 
 1 a 20 de 121 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Wu S, Han J, Feskanich D, Cho E, Stampfer MJ, Willett WC, Qureshi AA. Citrus consumption and risk of cutaneous malignant melanoma. Journal of Clinical Oncology 2015;33:2500-8. [Ref.ID 99223]
2. Cita con resumen
Anónimo. Suvorexant (Belsomra) for insomnia. Med Lett Drugs Ther 2015;57:29-31. [Ref.ID 98878]
3. Cita con resumen
Homberg MT, Tornio A, Joutsi-Korhonen L, Neuvonen M, Neuvonen PJ, Lassila R, Niemi M, Backman JT. Grapefruit juice markedly increases the plasma concentrations and antiplatelet effects of ticagrelor in healthy subjects. Br J Clin Pharmacol 2013;75:1488-96. [Ref.ID 95569]
4. Cita con resumen
Bailey DG, Dresser G, Arnold MO. Grapefruit-medication interactions: forbidden fruit or avoidable consequences? . Can Med Assoc J 2013;185:309-16. [Ref.ID 94799]
5. Cita con resumen
Pirmohamed M. Drug-grapefruit juice interactions. BMJ 2013;346:9. [Ref.ID 94758]
6. Cita con resumen
Anónimo. Transport d'anions ou de cations organiques et interactions. Prescrire 2012;32:676-7. [Ref.ID 93662]
7. Cita con resumen
Anónimo. Pamplemousses: des interactions avec les médicaments. Prescrire 2012;32:674-9. [Ref.ID 93661]
8. Cita con resumen
Shoaf SE, Mallikaarjun S, Bricmont P. Effect of grapefruit juice on the pharmacokinetics of tolvaptan, a non-peptide arginine vasopressin antagonist, in healthy subjects. Eur J Clin Pharmacol 2012;68:207-11. [Ref.ID 92330]
9.Enlace a cita original Cita con resumen
Anónimo. Statin drugs - Drug safety communication: class labeling change. U.S. Food and Drug Administration 2012:1 de marzo. [Ref.ID 92196]
10. Cita con resumen
Valenzuela B, Rebollo J, Pérez T, Brugarolas A, Pérez-Ruixo JJ. Effect of grapefruit juice on the pharmacokinetics of docetaxel in cancer patients: a case report. Br J Clin Pharmacol 2011;72:978-81. [Ref.ID 91878]
11. Cita con resumen
Anónimo. Medicines interactions: the role of P-glycoprotein. Prescriber Update 2011;32:21-2. [Ref.ID 91143]
12. Cita con resumen
Grande LA, Mendez RD, Krug RT, Verschuyl EJ. Attention - grapefruit!. Lancet 2009;373:1222. [Ref.ID 85567]
13. Cita con resumen
Baxter K, Sharp JM. Adverse drug interactions. Adv Drug React Bull 2008;248:951-4. [Ref.ID 82877]
14. Cita con resumen
15.
Ohnishi A, Ohtani H, Sawada Y. Major determinant factors of the extent of interaction between grapefruit juice and calcium channel antagonists. Br J Clin Pharmacol 2006;62:196-9. [Ref.ID 77785]
16.
Bidstrup TB, Damkier P, Olsen AK, Ekblom M, Karlsson A, Brosen K. The impact of CYP2C8 polymorphism and grapefruit juice on the pharmacokinetics of repaglinide. Br J Clin Pharmacol 2006;61:49-57. [Ref.ID 76103]
17.Tiene citas relacionadas
Fuhr U. Grapefruit juice - drug interactions. Independent commentary. Br J Clin Pharmacol 2004;58:S842-3. [Ref.ID 72384]
18.Tiene citas relacionadas
Bailey DG. Grapefruit juice - drug interactions. Author's commentary. Br J Clin Pharmacol 2004;58:S841-2. [Ref.ID 72383]
19.Tiene citas relacionadas
Bailey DG, Malcom J, Arnold O, Spence JD. Grapefruit juice - drug interactions. Br J Clin Pharmacol 2004;58:S831-40. [Ref.ID 72382]
20. Cita con resumen
Seleccionar todas
 
 1 a 20 de 121 siguiente >>